Agios Pharma (AGIO) Misses Q2 EPS by 22c

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.78), $0.22 worse than the analyst estimate of ($1.56). Revenue for the quarter came in at $11.35 million versus the consensus estimate of $9.62 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
• BofA lists top 5 themes driving next $1tn in incremental semi sales